Quarterly ResultJun 5, 2026, 04:52 PM

Cooper Companies Reports $77.9M Net Loss on $1.08B Sales

AI Summary

The Cooper Companies, Inc. reported a significant net loss of $77.9 million for the three months ended April 30, 2026, a sharp decline from a net income of $87.7 million in the same period last year. While net sales saw an increase to $1,081.5 million for the quarter and $2,105.6 million for the six months, the company was heavily impacted by a $271.6 million litigation expense related to CooperSurgical. This resulted in a substantial operating loss for the CooperSurgical segment and a consolidated net loss for the quarter. The company's total assets grew slightly to $12,482.3 million, but short-term debt saw a significant increase.

Key Highlights

Cooper Companies reported a net loss of $77.9 million for the three months ended April 30, 2026, compared to a net income of $87.7 million in the prior year period.
For the six months ended April 30, 2026, net income was $52.9 million, a significant decrease from $192.0 million in the same period last year.
Total net sales for the three months ended April 30, 2026, increased to $1,081.5 million from $1,002.3 million in the prior year.
Total net sales for the six months ended April 30, 2026, increased to $2,105.6 million from $1,967.0 million in the prior year.
CooperSurgical recorded an operating loss of $225.0 million for the three months ended April 30, 2026, compared to an operating income of $23.7 million in the prior year.
The company recorded a $271.6 million litigation expense, net of insurance recoveries, impacting the current period's results.
Total assets were $12,482.3 million as of April 30, 2026, compared to $12,394.8 million as of October 31, 2025.
Short-term debt increased significantly to $598.9 million as of April 30, 2026, from $47.8 million as of October 31, 2025.

View SEC Filing

COO

Ophthalmic Goods

COOPER COMPANIES, INC.

Price Impact